Trials / Recruiting
RecruitingNCT06922097
Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements
Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements: the Randomized RAPID Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 186 (estimated)
- Sponsor
- University of Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The RAPID trial is a randomized, single-center trial investigating whether giving atropine at heart rates below 60 beats per minute versus giving atropine only at heart rates below 30 beats per minute reduces the amount of norepinephrine needed to keep MAP above 65 mmHg in non-cardiac surgery patients with intraoperative bradycardia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Giving atropine at heart rates below 60 beats per minute | In patients assigned to the atropine therapy at heart rates below 60 beats per minute, atropine will be given at a dose of 0.5 mg when heart rate is below 60 beats per minute for one continuous minute. A second and third atropine dose of 0.5 mg will be given if heart rate remains or again drops below 60 beats per minute for one continuous minute. Patients will not be given more than 1.5 mg atropine. |
| DRUG | Giving atropine at heart rates below 30 beats per minute | In patients assigned to atropine therapy at heart rates below 30 beats per minute, atropine will be given at a dose of 0.5 mg when heart rate is below 30 beats per minute for one continuous minute. A second and third atropine dose of 0.5 mg will be given if heart rate remains or again drops below 30 beats per minute for one continuous minute. Patients will not be given more than 1.5 mg atropine. |
Timeline
- Start date
- 2025-04-07
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2025-04-10
- Last updated
- 2025-05-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06922097. Inclusion in this directory is not an endorsement.